Erectile dysfunction

American Family Physician

Volumn 54, Issue 5, 1996, Pages 1675-1682

  Greiner, K Allen ^a   Weigel, John W ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CHLORPROMAZINE; GLYCERYL TRINITRATE; MINOXIDIL; PAPAVERINE; PAROXETINE; PHENTOLAMINE; PROLACTIN; PROSTAGLANDIN E1; SODIUM CHLORIDE; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TRAZODONE; VERAPAMIL; YOHIMBINE;

AGE; ALCOHOLISM; ANAMNESIS; DIABETES MELLITUS; ENDOCRINE DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPOTENCE; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PENIS PROSTHESIS; PHYSICAL EXAMINATION; REVIEW; RISK FACTOR; SMOKING; SMOOTH MUSCLE RELAXATION; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; VASCULAR SURGERY;

HUMANS; IMPOTENCE; MALE; RISK FACTORS;

EID: 0029821256     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Impotence. NIH Consens Statement 1992;10(4):1-33.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
3. Virag R, Bouiily P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985;1(8422):181-4.
4. Gillespie JS, Liu X, Martin W. The neurotransmitter of the non-adrenergic non-cholinergic inhibitory nerves to smooth muscle of the genital system. In: Moncada S, Higgs EA, eds. Nitric oxide from L-arginine: a bioregulatory system. New York: Elsevier, 1990:147-64.
5. Ackerman MD, Carey MP. Psychology's role in the assessment of erectile dysfunction: historical precedents, current knowledge, and methods. J Consult Clin Psychol 1995;63:862-76.
6. Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995;80:3546-52.
7. Guay AT. Erectile dysfunction. Are you prepared to discuss it? Postgrad Med 1995;97:127-30,133-5,139-40.
8. Cookson MS, Nadig PW. Long-term results with vacuum constriction device. J Urol 1993;149:290-4.
9. Turner LA, Althof SE, Levine SB, Tobias TR, Kursh ED, Bodner D, et al. Treating erectile dysfunction with external vacuum devices: impact upon sexual, psychological and marital functioning. J Urol 1990; 144:79-82.
10. Sidi AA, Lewis JH. Clinical trial of a simplified vacuum erection device for impotence treatment. Urology 1992;39:526-8.
11. Gilbert HW, Gingell JC. Vacuum constriction devices: second-line conservative treatment for impotence. Br J Urol 1992;70:81-3.
12. Morales A, Condra M, Owen JA, Surridge DH, Fenemore J, Harris C. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 1987;137:1168-72.
13. Sondra LP, Mazo R, Chancellor MB. The role of yohimbine for the treatment of erectile impotence, J Sex Marital Ther 1990;16:15-21.
14. Cavallini G. Minoxidil versus nitroglycerin: a prospective double-blind controlled trial in transcutaneous erection facilitation for organic impotence. J Urol 1991;146:50-3.
15. Kim ED, el-Rashidy R, McVary KT. Papaverine topical gel for treatment of erectile dysfunction. J Urol 1995;153:361-5.
16. Kim ED, McVary KT. Topical prostaglandin-E1 for the treatment of erectile dysfunction. J Urol 1995; 153:1828-30.
17. Padma-Nathan H, Bennett A, Gesundheit N, et al. Treatment of erectile dysfunction by the medicated urethral system for erection (MUSE) [Abstract]. J Urol 1995;153:472.
18. Lipshultz LI. Injection therapy for erectile dysfunction [Editorial]. N Engl J Med 1996;334:913-4.
19. Govier FE, McClure RD, Weissman RM, Gibbons RP, Pritchett TR, Kramer-Levien D. Experience with triple-drug therapy in a pharmacological erection program. J Urol 1993;150:1822-4.
20. Bechara A, Casabe A, Cheliz G, Romano S, Fredotovich N. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine, phentolamine in nonresponders to high papaverine plus phentolamine doses. J Urol 1996;155:913-4.
21. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 1996;334:873-7.
22. Fallon B, Intracavernous injection therapy for male erectile dysfunction. Urol Clin North Am 1995; 22:83345.
23. Lakin MM, Montague DK, VanderBrug Medendorp S, Tesar L, Schover LR. Intracavernous injection therapy: analysis of results and complications. J Urol 1990;143:1138-41.
24. McLaren RH, Barrett DM. Patient and partner satisfaction with the AMS 700 penile prosthesis. J Urol 1992;147:62-5.
25. Rossman B, Mieza M, Melman A. Penile vein ligation for corporeal incompetence: an evaluation of short-term and long-term results. J Urol 1990;144: 679-82.